Physician profile
Christopher Haggerty
NPI 1609883479
$1,687.40
in general payments reported to CMS, 2019-2025
17 companies · $558 in 2025
The $558 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.02 · 2020: $14.54 · 2021: $58.06 · 2022: $73.70 · 2023: $310 · 2024: $606 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $553.58 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $288.31 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $230.50 | 2021-2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $116.59 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $99.50 | 2023-2025 | Acthar |
| Amgen INC. | $58.21 | 2024 | Tepezza |
| Dompe US, INC. | $54.88 | 2021-2025 | Oxervate |
| Biotissue Holdings INC. | $46.91 | 2023-2024 | |
| Thea Pharma INC. | $46.88 | 2025 | Iyuzeh |
| Bausch & Lomb Americas INC. | $39.97 | 2024-2025 | Xiidra, Miebo |
| Allergan, INC. | $30.67 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26.47 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $24.90 | 2025 | Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $23.42 | 2019 | |
| Virtus Pharmaceuticals LLC | $17.89 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $16.69 | 2025 | Rocklatan |
| Oyster Point Pharma, INC. | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Haggerty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.